“…Fluorescence lifetime imaging microscopy (FLIM) was used to analyze NAD(P)H in exfoliated cervical cells from healthy volunteers and patients with different degrees of cancerization. The results showed that cancer cells have a relatively short average fluorescence lifetime and less protein-bound NAD(P)H ratio and are more prone to glycolysis than OXPHOS compared with normal cells [ 106 ]. Chen et al [ 107 ] identified 293 NAD + metabolic-related genes and 21 prognostic NAD + metabolic-related genes in 39 CC patients: ADAMTS10, ANGPTL5, APCDD1L, CCDC85A, CGREF1, CHRDL2, CRP, DENND5B, EFS, FGF8, P4HA3, PCDH20, PCDHAC2, RASGRF2, S100P, SLC19A3, SLC6A14, TESC, TFPI, TNMD, ZNF229 , and for the first time described SLC19A3 as a prognostic signature through NAD + metabolism, providing clinical prognostic biomarkers and therapeutic targets for CC.…”